- Home
- FNF vs GH Comparison
FNF vs GH Comparison
Compare FNF & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNF | GH |
|---|---|---|
| Founded | 1847 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 10.9B |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FNF | GH |
|---|---|---|
| Price | $51.95 | $87.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 19 |
| Target Price | $60.50 | ★ $119.79 |
| AVG Volume (30 Days) | 1.5M | ★ 2.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.98% | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ 2.21 | N/A |
| Revenue | ★ $14,445,000,000.00 | $982,021,000.00 |
| Revenue This Year | $10.90 | $33.30 |
| Revenue Next Year | $5.44 | $28.27 |
| P/E Ratio | $23.72 | ★ N/A |
| Revenue Growth | 5.58 | ★ 32.88 |
| 52 Week Low | $42.78 | $36.36 |
| 52 Week High | $65.21 | $120.74 |
Technical Indicators
Market Signals| Indicator | FNF | GH |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 49.22 |
| Support Level | $50.82 | $82.33 |
| Resistance Level | $59.52 | $90.28 |
| Average True Range (ATR) | 1.09 | 4.67 |
| MACD | 0.37 | 0.06 |
| Stochastic Oscillator | 85.85 | 53.37 |
Price Performance
Historical ComparisonAbout FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.